[PLX] YoY Annual Result on 31-Dec-2016 [#FY]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
16-Mar-2017
Financial Year
2016
Quarter
31-Dec-2016 [#FY]
Profit Trend
YoY- -150.60%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Annual Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 54,693 34,240 19,242 9,199 4,364 15,160 11,513 29.64%
PBT -18,276 -26,457 -85,276 -29,176 -27,282 -29,943 -27,790 -6.74%
Tax 7,966 536 7,805 10,854 -87,566 -2,944 0 -
NP -26,242 -26,457 -85,276 -29,365 58,037 -29,943 -27,790 -0.95%
Tax Rate - - - - - - - -
Total Cost 80,935 60,697 104,518 38,564 -53,673 45,103 39,303 12.78%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin -47.98 -77.27 -443.18 -319.22 1,329.90 -197.51 -241.38 -23.59%
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS -1.77 -1.80 -6.51 -0.29 0.61 -0.32 -0.30 34.40%
EPS Diluted -1.77 -1.80 -6.51 -0.29 0.61 -0.32 -0.30 34.40%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.